Was sind die meistzitierten Publikationen aus dem Bereich Multiple Sklerose (MS)? Was ist der Inhalt dieser Artikel? Wer sind die Autoren? Wo und wann sind die Artikel erschienen?
Mich hat diese Frage einmal wunder genommen. So habe ich in der Web of Science Datenbank von Thomson Reuters nach allen Multiple Sklerose Publikationen gesucht. Die Web of Science Datenbank erfasst die wissenschaftlichen Publikationen mit ihren Zusatzdaten wie Autoren, Referenzen und Sponsoren. Als Zitationen werden Referenzen bzw. Verweise auf andere wissenschaftliche Publikationen bezeichnet. Zitationen und Publikationen können mit der Web of Science Datenbank analysiert werden. Auf wichtige, spannende oder kontroverse Artikel wird häufiger Bezug genommen. Der Artikel Was ist gute Wissenschaft? befasst sich ebenfalls mit dieser Publikationsdatenbank und der Zitationsanalyse.
Bei meiner Anfrage wurden in der Datenbank 51’539 Publikationen zum Thema Multiple Sklerose gefunden. In der Tabelle sind die 50 meistzitierten Publikationen aufgelistet.
Anzahl Zitationen
Erscheinungsjahr und Fachzeitschrift
Autoren
1.
NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS
5637 times cited
1983 Annals Of Neurology
Poser, Cm; Paty, Dw; Scheinberg, L; Mcdonald, Wi; Davis, Fa; Ebers, Gc; Johnson, Kp; Sibley, Wa; Silberberg, Dh; Tourtellotte, Ww
2.
RATING NEUROLOGIC IMPAIRMENT IN MULTIPLE-SCLEROSIS - AN EXPANDED DISABILITY STATUS SCALE (EDSS)
4714 times cited
1983 Neurology
Kurtzke, Jf
3.
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
2505 times cited
2001 Annals Of Neurology
Mcdonald, Wi; Compston, A; Edan, G; Goodkin, D; Hartung, Hp; Lublin, Fd; Mcfarland, Hf; Paty, Dw; Polman, Ch; Reingold, Sc; Sandberg-Wollheim, M; Sibley, W; Thompson, Aj; Van Den Noort, S; Weinshenker, By; Wolinsky, Js
4.
Axonal transection in the lesions of multiple sclerosis
1884 times cited
1998 New England Journal Of Medicine
Trapp, Bd; Peterson, J; Ransohoff, Rm; Rudick, R; Mork, S; Bo, L
5.
Vitamin D deficiency
1441 times cited
2007 New England Journal Of Medicine
Holick, Mf
6.
Defining the clinical course of multiple sclerosis: Results of an international survey
1432 times cited
1996 Neurology
Lublin, Fd; Reingold, Sc
7.
Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis
1381 times cited
1996 Annals Of Neurology
Jacobs, Ld; Cookfair, Dl; Rudick, Ra; Herndon, Rm; Richert, Jr; Salazar, Am; Fischer, Js; Goodkin, De; Granger, Cv; Simon, Jh; Alam, Jj; Bartoszak, Dm; Bourdette, Dn; Braiman, J; Brownscheidle, Cm; Coats, Me; Cohan, Sl; Dougherty, Ds; Kinkel, Rp; Mass, Mk; Munschauer, Fe; Priore, Rl; Pullicino, Pm; Scherokman, Bj; Weinstockguttman, B; Whitman, Rh; Baird, Wc; Fillmore, M; Bona, Lm; Colonruiz, Me; Nadine, Bs; Donovan, A; Bennett, S; Kieffer, Ym; Umhauer, Ma; Miller, Ce; Kilic, Ak; Sargent, El; Schachter, M; Shucard, Dw; Weider, V; Catalano, Ba; Cervi, Jm; Czekay, C; Farrell, Jl; Filippini, Js; Matyas, Rc; Michienzi, Ke; Ito, M; Omalley, Ja; Zielezny, Ma; Brun, Jm; Davidson, Al; Green, La; Oreilly, Km; Shelton, Ja; Wende, Ke; Barilla, Dy; Boyle, Sl; Perkins, Kk; Perryman, Je; Stiebeling, Bg; Konecsni, Jf; Ross, Js; Choi, Ks; Gustafson, Cj; Quandt, Bj; Scherzinger, Al; Griffith, Da; Harris, Jm; Lezak, Md; Mimica, I; Saunders, Ja; Coit, We; Force, Cr; Gilmore, Fj; Harris, Lb; Jones, Mm; Kauffman, Ja; Marberger, Ke; Mcbride, Jw; Miller, Ll; Wright, Gk; Brooks, Ja; Brown, Hr; Graves, Me; Schmidt, Ja; Mothena, Jw; Grafman, Jh; Kenworthy, Mk; Morton, Mm; Brown, Dm; Brown, Dc; Levy, Lm; Borden, Ec; Ransohoff, Rm; Vilcek, Jt; Mccarthykirby, K; Campion, M
8.
REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS
1378 times cited
1994 Science
Chen, Yh; Kuchroo, Vk; Inobe, J; Hafler, Da; Weiner, Hl
9.
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
1249 times cited
2005 Journal Of Experimental Medicine
Langrish, Cl; Chen, Y; Blumenschein, Wm; Mattson, J; Basham, B; Sedgwick, Jd; Mcclanahan, T; Kastelein, Ra; Cua, Dj
10.
INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
1238 times cited
1993 Neurology
Duquette, P; Girard, M; Despault, L; Dubois, R; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Lapierre, Y; Antel, J; Freedman, M; Hum, S; Greenstein, Ji; Mishra, B; Muldoon, J; Whitaker, Jn; Evans, Bk; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Moore, Grw; Hashimoto, Sa; Morrison, W; Nelson, J; Goodin, Ds; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Wallenberg, Jc; Bedell, L; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Pachner, A; Taylor, W
11.
Medical progress: Multiple sclerosis.
1174 times cited
2000 New England Journal Of Medicine
Noseworthy, Jh; Lucchinetti, C; Rodriguez, M; Weinshenker, Bg
12.
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
1059 times cited
2000 Annals Of Neurology
Lucchinetti, C; Bruck, W; Parisi, J; Scheithauer, B; Rodriguez, M; Lassmann, H
13.
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald Criteria”
1050 times cited
2005 Annals Of Neurology
Polman, Ch; Reingold, Sc; Edan, G; Filippi, M; Hartung, Hp; Kappos, L; Lublin, Fd; Metz, Lm; Mcfarland, Hf; O’Connor, Pw; Sandberg-Wollheim, M; Thompson, Aj; Weinshenker, Bg; Wolinsky, Js
14.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
1043 times cited
1998 Lancet
Ebers, Gc; Rice, G; Lesaux, J; Paty, D; Oger, J; Li, Dkb; Beall, S; Devonshire, V; Hashimoto, S; Hooge, J; Kastrukoff, L; Krieger, C; Mezei, M; Seland, P; Vorobeychi, G; Morrison, W; Nelson, J; Freedman, Ms; Chrisie, S; Nelson, R; Rabinovitch, H; Freedman, C; Hartung, Hp; Rieckmann, P; Archelos, J; Jung, S; Weilbach, F; Flachenecke, P; Sauer, J; Hommes, O; Jongen, P; Brouwer, S; Mcleod, J; Pollard, J; Ng, R; Sandberg-Wollheim, M; Kallen, K; Nilsson, P; Ekberg, R; Lundgren, A; Jadback, G; Wikstrom, J; Multanen, J; Valjakka, M; Carton, H; Lissoir, F; Declerq, I; Vieren, M; Peeters, E; Dubois, B; Dekeersmaeker, E; Van Herle, A; Hughes, Rac; Sharrack, B; Soudain, S; Panelius, M; Eralinna, J; Soilu-Hanninen, M; Murto, S; Medaer, R; Broeckx, J; Vanroose, E; Bogaers, A; Blumhardt, Ld; Edwards, S; Liu, C; Orpe, V; Barnes, D; Schwartz, M; Stoy, N; Harraghy, C; Bertelsmann, F; Uitdehaag, B; Nasseri, K; Chofflon, M; Roth, S; Kappos, L; Huber, S; Bellaiche, Y; Senn, C; King, J; Jubert, J; Whitten, S; Newsom-Davis, Jm; Palace, J; Lee, M; Evangelou, N; Pinto, A; Cavey, A; Sindic, Cjm; Monteyne, P; Verougstraete, D; Van Doorn, Pa; Moll, W; Visser, L; Willems, M; Martina, I; Buljevac, D; Loman, L; Bates, D; Pandit, D; Irving, J; Rhodes, B; Riddehough, A; Zhao, Gj; Wang, X; Cheng, Y; Ammoury, N; Dupont, F; Galazka, A; Hyde, R; Olson, M; Pernin, Mo; Abdul-Ahad, Ak; Hommes, O; Noseworthy, J; Borden, E; O’Brien, P; Wolinsky, J
15.
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS - REPORT BY PANEL ON EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
1039 times cited
1965 Annals Of The New York Academy Of Sciences
Schumach.Ga; Beebe, G; Kibler, Rf; Kurland, Lt; Kurtzke, Jf; Mcdowell, F; Nagler, B; Sibley, Wa; Tourtell.Ww; Willmon, Tl
16.
THE FATIGUE SEVERITY SCALE - APPLICATION TO PATIENTS WITH MULTIPLE-SCLEROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
1028 times cited
1989 Archives Of Neurology
Krupp, Lb; Larocca, Ng; Muirnash, J; Steinberg, Ad
17.
PREVENTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ANTIBODIES AGAINST ALPHA-4-BETA-1 INTEGRIN
943 times cited
1992 Nature
Yednock, Ta; Cannon, C; Fritz, Lc; Sanchezmadrid, F; Steinman, L; Karin, N
18.
MOLECULAR MIMICRY IN T-CELL-MEDIATED AUTOIMMUNITY - VIRAL PEPTIDES ACTIVATE HUMAN T-CELL CLONES SPECIFIC FOR MYELIN BASIC-PROTEIN
937 times cited
1995 Cell
Wucherpfennig, Kw; Strominger, Jl
19.
COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
923 times cited
1995 Neurology
Johnson, Kp; Brooks, Br; Cohen, Ja; Ford, Cc; Goldstein, J; Lisak, Rp; Myers, Lw; Panitch, Hs; Rose, Jw; Schiffer, Rb; Vollmer, T; Weiner, Lp; Wolinsky, Js; Bird, Sj; Constantinescu, C; Kolson, Dl; Gonzalezscarano, F; Brennan, D; Pfohl, D; Mandler, Rn; Rosenberg, Ga; Jeffrey, C; Barger, Gr; Gandhi, B; Moore, Pm; Rogers, Lr; Lisak, D; Smith, L; Ellison, Gw; Baumhefner, Rw; Craig, Sl; Jalbut, Ss; Katz, E; Conway, Kl; Burns, Jb; Shiba, C; Giang, Dw; Petrie, Md; Guarnaccia, Jb; Anderson, S; Mckeon, A; Mccarthy, M; Thomas, Ab; Vriesendorp, Fj; Austin, Sg; Lindsey, Jw; Dimachkie, M; Cerreta, E; Kachuck, N; Mccarthy, Ka; Fleming, J; Parnell, Jh; Tamulevich, J; Weasler, C; Kadosh, S; Halt, H; Stark, Y; Pinchasi, I; Spiller, N; Vandennoort, S; Miller, A; Mellits, D; Hopkins, J; Reingold, S; Gomolin, Ih
20.
PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES
911 times cited
1994 Nature
Gearing, Ajh; Beckett, P; Christodoulou, M; Churchill, M; Clements, J; Davidson, Ah; Drummond, Ah; Galloway, Wa; Gilbert, R; Gordon, Jl; Leber, Tm; Mangan, M; Miller, K; Nayee, P; Owen, K; Patel, S; Thomas, W; Wells, G; Wood, Lm; Woolley, K
21.
INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS .2. MRI ANALYSIS RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
892 times cited
1993 Neurology
Paty, Dw; Li, Dkb; Duquette, P; Girard, M; Despault, L; Dubois, R; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Lapierre, Y; Antel, J; Freedman, M; Hum, S; Greenstein, Ji; Mishra, B; Muldoon, J; Whitaker, Jn; Evans, Bk; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Moore, Grw; Hashimoto, Sa; Morrison, W; Nelson, J; Goodin, Ds; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Wallenberg, Jc; Bedell, L; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Pachner, A; Taylor, W
22.
Apoptosis in the nervous system
890 times cited
2000 Nature
Yuan, Jy; Yankner, Ba
23.
AN ADVERSE PROPERTY OF A FAMILIAL ALS-LINKED SOD1 MUTATION CAUSES MOTOR-NEURON DISEASE CHARACTERIZED BY VACUOLAR DEGENERATION OF MITOCHONDRIA
837 times cited
1995 Neuron
Wong, Pc; Pardo, Ca; Borchelt, Dr; Lee, Mk; Copeland, Ng; Jenkins, Na; Sisodia, Ss; Cleveland, Dw; Price, Dl
24.
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
831 times cited
2003 Biochemical Journal
Heinrich, Pc; Behrmann, I; Haan, S; Hermanns, Hm; Muller-Newen, G; Schaper, F
25.
The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
808 times cited
1998 Annual Review Of Immunology
Gately, Mk; Renzetti, Lm; Magram, J; Stern, As; Adorini, L; Gubler, U; Presky, Dh
26.
LYMPHOCYTE-T ENTRY INTO THE CENTRAL-NERVOUS-SYSTEM
798 times cited
1991 Journal Of Neuroscience Research
Hickey, Wf; Hsu, Bl; Kimura, H
27.
IMMUNOLOGICAL ASPECTS OF DEMYELINATING DISEASES
788 times cited
1992 Annual Review Of Immunology
Martin, R; Mcfarland, Hf; Mcfarlin, De
28.
COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS .1. FREQUENCY, PATTERNS, AND PREDICTION
782 times cited
1991 Neurology
Rao, Sm; Leo, Gj; Bernardin, L; Unverzagt, F
29.
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS
779 times cited
1964 Practitioner
Ashworth, B
30.
Axonal damage in acute multiple sclerosis lesions
778 times cited
1997 Brain
Ferguson, B; Matyszak, Mk; Esiri, Mm; Perry, Vh
31.
ORAL TOLERANCE - IMMUNOLOGICAL MECHANISMS AND TREATMENT OF ANIMAL AND HUMAN ORGAN-SPECIFIC AUTOIMMUNE-DISEASES BY ORAL-ADMINISTRATION OF AUTOANTIGENS
767 times cited
1994 Annual Review Of Immunology
Weiner, Hl; Friedman, A; Miller, A; Khoury, Sj; Alsabbagh, A; Santos, L; Sayegh, M; Nussenblatt, Rb; Trentham, De; Hafler, Da
32.
INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
748 times cited
1995 Neurology
Duquette, P; Despault, L; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Freedman, M; Lapierre, Y; Greenstein, Ji; Mishra, B; Delillio, N; Whitaker, J; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Morrison, W; Nelson, J; Goodin, D; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Li, Dkb; Tanton, El; Zhao, Gj; Flak, B; Riddehough, A; Cover, K; Rhodes, B; Cook, A; Smith, K; Costley, L; Renneberg, S; Shaw, T; Genton, M; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Taylor, W; Wallenberg, Jc; Bedell, L
33.
Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases
719 times cited
2002 New England Journal Of Medicine
Bach, Jf
34.
Chemokines and disease
712 times cited
2001 Nature Immunology
Gerard, C; Rollins, Bj
35.
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells
688 times cited
2006 Journal Of Experimental Medicine
Liu, Wh; Putnam, Al; Xu-Yu, Z; Szot, Gl; Lee, Mr; Zhu, S; Gottlieb, Pa; Kapranov, P; Gingeras, Tr; Fazekas De St Groth, B; Clayberger, C; Soper, Dm; Ziegler, Sf; Bluestone, Ja
36.
Loss of functional suppression by CD4(+)CD25(+) regulatory T cells in patients with multiple sclerosis
686 times cited
2004 Journal Of Experimental Medicine
Viglietta, V; Baecher-Allan, C; Weiner, Hl; Hafler, Da
37.
The glial scar and central nervous system repair
682 times cited
1999 Brain Research Bulletin
Fawcett, Jw; Asher, Ra
38.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
676 times cited
2000 New England Journal Of Medicine
Jacobs, Ld; Beck, Rw; Simon, Jh; Kinkel, Rp; Brownscheidle, Cm; Murray, Tj; Simonian, Na; Slasor, Pj; Sandrock, Aw
39.
Diffusion tensor imaging: Concepts and applications
671 times cited
2001 Journal Of Magnetic Resonance Imaging
Le Bihan, D; Mangin, Jf; Poupon, C; Clark, Ca; Pappata, S; Molko, N; Chabriat, H
40.
THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS - A GEOGRAPHICALLY BASED STUDY
668 times cited
1989 Brain
Weinshenker, Bg; Bass, B; Rice, Gpa; Noseworthy, J; Carriere, W; Baskerville, J; Ebers, Gc
41.
TNF-R1 signaling: A beautiful pathway
667 times cited
2002 Science
Chen, Gq; Goeddel, Dv
42.
T-CELL RECOGNITION OF AN IMMUNODOMINANT MYELIN BASIC-PROTEIN EPITOPE IN MULTIPLE-SCLEROSIS
655 times cited
1990 Nature
Ota, K; Matsui, M; Milford, El; Mackin, Ga; Weiner, Hl; Hafler, Da
43.
ORAL TOLERANCE TO MYELIN BASIC-PROTEIN AND NATURAL RECOVERY FROM EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ARE ASSOCIATED WITH DOWN-REGULATION OF INFLAMMATORY CYTOKINES AND DIFFERENTIAL UP-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND PROSTAGLANDIN-E EXPRESSION IN THE BRAIN
652 times cited
1992 Journal Of Experimental Medicine
Khoury, Sj; Hancock, Ww; Weiner, Hl
44.
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
635 times cited
2003 Journal Of Biological Chemistry
Aggarwal, S; Ghilardi, N; Xie, Mh; De Sauvage, Fj; Gurney, Al
45.
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
622 times cited
2006 New England Journal Of Medicine
Polman, Ch; O’Connor, Pw; Havrdova, E; Hutchinson, M; Kappos, L; Miller, Dh; Phillips, Jt; Lublin, Fd; Giovannoni, G; Wajgt, A; Toal, M; Lynn, F; Panzara, Ma; Sandrock, Aw
46.
THE MULTIDIMENSIONAL FATIGUE INVENTORY (MFI) PSYCHOMETRIC QUALITIES OF AN INSTRUMENT TO ASSESS FATIGUE
618 times cited
1995 Journal Of Psychosomatic Research
Smets, Ema; Garssen, B; Bonke, B; Dehaes, Jcjm
47.
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
618 times cited
2006 New England Journal Of Medicine
Charo, If; Ransohoff, Rm
48.
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
617 times cited
2002 Nature Medicine
Lock, C; Hermans, G; Pedotti, R; Brendolan, A; Schadt, E; Garren, H; Langer-Gould, A; Strober, S; Cannella, B; Allard, J; Klonowski, P; Austin, A; Lad, N; Kaminski, N; Galli, Sj; Oksenberg, Jr; Raine, Cs; Heller, R; Steinman, L
49.
IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS
597 times cited
1991 Journal Of Clinical Investigation
Selmaj, K; Raine, Cs; Cannella, B; Brosnan, Cf
50.
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
597 times cited
1998 Lancet
Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; Hern, J; Coleman, R; Gerrie, L; Cooper, G; Moore, J; Boringa, J; Van Oosten, B; Ronner, H; Schrijver, H; Truyen, L; Montalban, J; Rio, J; Tintore, M; Jacas, C; Marzo, E; Lechner-Scott, J; Huber, S; Lienert, C; Brunnschweiler, H; Hawkins, S; Droogan, A; Mcdonnell, G; Duddy, M; Mckinstry, S; Altenkirch, H; Baum, K; Einhaupl, K; Marx, P; Poewe, W; Walter, G; Akman, H; Brockmeier, B; Scherer, P; Zschenderlein, R; Schmierer, K; Gelderblom, H; Hartmann, A; Stapf, C; Luschow, A; Mackert, B; Schumacher, H; Masuhr, F; Hempel, T; Zimmermann, R; Munch, M; Francis, D; Heafield, M; Al-Memar, A; Winer, J; Chong, M; Brochet, B; Gayou, A; Auriacombe, S; Dousset, V; Wiles, C; Thomas, F; Pickersgill, T; Hinds, N; Dawson, K; Hughes, T; Hutchinson, M; Murphy, R; Redmond, J; Webb, S; Stoll, G; Jander, S; Hagemann, G; Koller, H; Hanemann, C; Kolmel, H; Reichel, D; Petereit, K; Thieme, A; Khatami, A; Neumann, M; Amaducci, L; Massacesi, L; Siracusa, G; Amato, M; Bartolozzi, L; Repice, A; Minderhoud, J; De Keyser, J; Zorgdrager, A; Zwanikken, C; Poser, S; Polak, T; Gunther, A; Bitsch, A; Borner, T; Weber, F; Wikstrom, J; Farkkila, M; Majuri, H; Sumelahti, M; Telakivi, T; Fredrikson, S; Martin, C; Miller, D; O’Riordan, J; Brex, P; Kapoor, R; Werring, D; Confavreux, C; Brunet, P; Hannoun, D; Brudon, F; Moreau, T; Blanc, S; D’Hooghe, M; Jacobs, K; Lissoir, F; Demonty, L; Comi, G; Colombo, B; Rossi, P; Rodegher, M; Santuccio, G; Martinelli, F; Hohlfeld, R; Walther, E; Goebels, N; Dang, T; Lindert, R; Voltz, R; Cartlidge, N; Bates, D; Moran, G; Pandit, L; Westwood, M; Haller, P; Sommer, J; Bitter, J; Suss, F; Mellies, J; Mucha, P; Lyon-Caen, O; Degos, Jd; Roullet, E; Lubetzki, C; Creange, A; Tourbah, A; Pez, D; Lecanuet, P; Nicolt, P; Edan, G; Belliard, S; De Marco, O; Cahagne, V; De Burghgraeve, V; Brunet, I; Fieschi, C; Millefiorini, E; Gasperini, C; Buttinelli, C; Frontini, M; Howell, S; Hadjivassiliou, M; Gibson, A; Graham, A; Harkness, K; Lawden, M; Clanet, M; Wauban, E; Azais-Vuillemin, C; Lau, Gkk; Louis, C; Panelius, M; Ruutiainen, J; Eralinna, J; Soilu-Hanninen, M; Gold, R; Hartung, Hp; Jung, S; Bayas, A; Flachenecker, P; Weilbach, F; Archelos, J; Kollegger, H; Vass, K; Asenbaum, S; Chatsakos, T; Beckmann, K; Ghazi, M; Wagner, K; Miltenburger, C; Mcfarland, H; Petkau, J; Sabouraud, O; Toyka, K
Tabelle: Die 50 meistzitierten Multiple Sklerose Publikationen. Datenquelle: Web of Science, Stand: 30.08.2011
Methode
Ich habe folgende Suchanfrage im Web of Science verwendet:
- Topic=(multiple AND sclerosis)
- Refined by: Document Type=( ARTICLE OR EDITORIAL MATERIAL OR REVIEW OR PROCEEDINGS PAPER OR LETTER )
- Keine zeitliche Einschränkung.
Diskussion
Interessanterweise sind die Top 3 der zitierten Werke keine Forschungsresultate, sondern Forschungsanleitungen und -richtlinien.
Ludwig Kappos von der Universität Basel und Norbert Goebels konnte ich als Schweizer Forscher in dieser Liste finden. Prof. Dr. Ludwig Kappos hat an den Publikationen Nr. 13, 14, 45 und 50 mitgearbeitet.
Von der DMSG sind die Herren Hans-Peter Hartung, Ralf Gold, Klaus V. Toyka und Reinhard Hohlfeld in der Tabelle enthalten.
